Cargando…

Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023

Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Leal, Marcos André Soares, de Almeida, Thanisia, Torres, João Guilherme, Gastalho Campos, Luciene Cristina, Vasquez, Elisardo Corral, Barauna, Valério Garrone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094174/
https://www.ncbi.nlm.nih.gov/pubmed/32259102
http://dx.doi.org/10.1155/2020/3092721
_version_ 1783510414090305536
author Leal, Marcos André Soares
de Almeida, Thanisia
Torres, João Guilherme
Gastalho Campos, Luciene Cristina
Vasquez, Elisardo Corral
Barauna, Valério Garrone
author_facet Leal, Marcos André Soares
de Almeida, Thanisia
Torres, João Guilherme
Gastalho Campos, Luciene Cristina
Vasquez, Elisardo Corral
Barauna, Valério Garrone
author_sort Leal, Marcos André Soares
collection PubMed
description Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental models. Angiotensin II is one of the active peptides of the renin-angiotensin system and exerts its effect through the AT1 and AT2 receptors. Some studies seek to understand the effects of angiotensin II receptors at the vascular level by using vascular reactivity experiments. However, because of the large number of variations, there are only a handful of reactivity studies that seek to use this method. Thus, the objective of this study was to standardize experimental methods with angiotensin II, through vascular reactivity protocols. For this, variables such as basal tension, concentration interval, single concentration, curve concentration response, and multiple experiments using the same aortic ring were developed using the technique of vascular reactivity in an organ bath. This is the first study that has standardized the vascular reactivity protocol. In addition, we demonstrated the effects of TRV023-biased ligand of the AT1R at vascular sites.
format Online
Article
Text
id pubmed-7094174
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70941742020-04-01 Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 Leal, Marcos André Soares de Almeida, Thanisia Torres, João Guilherme Gastalho Campos, Luciene Cristina Vasquez, Elisardo Corral Barauna, Valério Garrone Adv Pharmacol Pharm Sci Research Article Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental models. Angiotensin II is one of the active peptides of the renin-angiotensin system and exerts its effect through the AT1 and AT2 receptors. Some studies seek to understand the effects of angiotensin II receptors at the vascular level by using vascular reactivity experiments. However, because of the large number of variations, there are only a handful of reactivity studies that seek to use this method. Thus, the objective of this study was to standardize experimental methods with angiotensin II, through vascular reactivity protocols. For this, variables such as basal tension, concentration interval, single concentration, curve concentration response, and multiple experiments using the same aortic ring were developed using the technique of vascular reactivity in an organ bath. This is the first study that has standardized the vascular reactivity protocol. In addition, we demonstrated the effects of TRV023-biased ligand of the AT1R at vascular sites. Hindawi 2020-02-21 /pmc/articles/PMC7094174/ /pubmed/32259102 http://dx.doi.org/10.1155/2020/3092721 Text en Copyright © 2020 Marcos André Soares Leal et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Leal, Marcos André Soares
de Almeida, Thanisia
Torres, João Guilherme
Gastalho Campos, Luciene Cristina
Vasquez, Elisardo Corral
Barauna, Valério Garrone
Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
title Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
title_full Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
title_fullStr Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
title_full_unstemmed Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
title_short Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
title_sort physiological and biochemical vascular reactivity parameters of angiotensin ii and the action of biased agonist trv023
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094174/
https://www.ncbi.nlm.nih.gov/pubmed/32259102
http://dx.doi.org/10.1155/2020/3092721
work_keys_str_mv AT lealmarcosandresoares physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023
AT dealmeidathanisia physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023
AT torresjoaoguilherme physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023
AT gastalhocamposlucienecristina physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023
AT vasquezelisardocorral physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023
AT baraunavaleriogarrone physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023